Treatment with antihypertensive agents, ACE inhibitors, angiotensin receptor blockers (ARBs), a direct renin inhibitor, and MR blockers are all known to increase the risk of hyperkalemia [59, 80, 81]. Here, NR3C2 is linked to Hyperkalemia.